Carregant...
A146 ASSESSMENT OF THE USE OF THERAPEUTIC DRUG MONITORING OF INFLIXIMAB DURING MAINTENANCE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
BACKGROUND: Infliximab (IFX) was proven effective in the induction and maintenance of remission in inflammatory bowel diseases (IBD) in both children and adults. There is a significant number of individual who lose response to the medication. Measurable IFX drug levels correlate with clinical respon...
Guardat en:
| Publicat a: | J Can Assoc Gastroenterol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507680/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.147 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|